# 2025年12月6日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 结直肠癌中细胞外囊泡货物的协同调控：免疫逃逸、基质重塑与治疗前沿

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41351158)
**期刊：** Molecular cancer
**PMID：** 41351158
**DOI：** 10.1186/s12943-025-02532-2

### 第一部分 原文与翻译

**英文原标题：** Extracellular vesicles cargo orchestration in colorectal cancer: immune evasion, stromal remodeling, and therapeutic frontiers.

> **英文摘要：**
> Extracellular vesicles (EVs), as pivotal "messengers" in intercellular communication within the tumor microenvironment (TME), play multifaceted regulatory roles in the initiation, progression, and therapeutic response of colorectal cancer (CRC). This review focuses on the roles of EVs in CRC progression, including the creation of an immunosuppressive microenvironment and the modulation of other cells within the TME. Additionally, the article briefly discusses the potential biomarker value of EVs for early diagnosis and metastasis prediction. Furthermore, several therapeutic strategies employing EVs for CRC treatment are introduced, such as adjuvant immunotherapy, the use of stem cell-derived EVs, and engineered EVs. In this context, we emphasize the limitations and challenges of EV-based research and explore the future prospects of this field, aiming towards the realization of its practical application in the precise diagnosis and treatment of CRC.

> **中文摘要：**
> 细胞外囊泡（EVs）作为肿瘤微环境（TME）中细胞间通信的关键“信使”，在结直肠癌（CRC）的发生、进展及治疗反应中发挥多层面的调控作用。本综述重点探讨EVs在CRC进展中的作用，包括其在形成免疫抑制性微环境及调节TME内其他细胞方面的功能。此外，本文简要讨论了EVs在早期诊断与转移预测中的潜在生物标志物价值。进一步地，文章介绍了若干利用EVs进行CRC治疗的策略，如辅助手段的免疫治疗、来源于干细胞的EVs以及工程化EVs。在此背景下，我们强调了基于EV研究的局限性与挑战，并展望了该领域未来的发展前景，旨在推动其在CRC精准诊断与治疗中的实际应用。

### 第二部分 AI 大师评价

本综述系统总结了细胞外囊泡在结直肠癌的免疫调控、基质重塑及治疗策略中的关键作用，突出其作为沟通信使的多样功能。作者不仅阐述了EVs如何塑造免疫抑制性微环境，还评估了其作为早期诊断与转移预测生物标志物的潜力。同时，文中梳理了基于EV的多种治疗途径，包括免疫联合、干细胞源EV及工程化EV应用。该研究具有前瞻性与综合性，但仍需更多临床验证以解决标准化和转化应用的挑战。

---

## 2. 细菌脂多糖可改变结直肠癌细胞的DNA甲基化状态

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41351128)
**期刊：** Clinical epigenetics
**PMID：** 41351128
**DOI：** 10.1186/s13148-025-02012-w

### 第一部分 原文与翻译

**英文原标题：** Bacterial lipopolysaccharide alters DNA methylation in colorectal cancer cells.

> **英文摘要：**
> Colorectal cancer (CRC) is commonly associated with epigenetic modifications, including altered DNA methylation. Recent studies suggest that tumour-resident bacteria may influence CRC development, yet the impact of bacteria on epigenetic regulation is not understood. This study investigates the effect of lipopolysaccharide (LPS) from Fusobacterium periodonticum and Bacteroides fragilis, bacteria that are abundant in CRC tumours with high CpG island methylator phenotype (CIMP), on DNA methylation in HT29 colorectal cancer cells. HT29 cells were treated with LPS from F. periodonticum, B. fragilis, or a combination of both. DNA methylation was assessed using reduced representation bisulfite sequencing (RRBS), followed by bioinformatic analysis to identify differentially methylated CpG sites. RT-qPCR was used to analyse the expression of selected genes with altered CpG promoter methylation. F. periodonticum LPS treatment induced both hypermethylation and hypomethylation in HT29 cells, with significant hypermethylation observed near specific promoter regions, including PEPD and VAV3, with associated decrease in gene expression of these genes. B. fragilis LPS treatment predominantly induced hypomethylation. Co-treatment with both LPS molecules resulted in distinct methylation patterns, with B. fragilis LPS attenuating F. periodonticum LPS-induced hypermethylation. Bacterial LPS can induce dynamic alterations in DNA methylation profiles in HT29 colorectal cancer cells, leading to changes in gene expression. These findings suggest a novel link between tumour-resident bacteria and DNA methylation in colorectal cancer, highlighting, for the first time, a potential mechanism by which bacteria may influence colorectal carcinogenesis.

> **中文摘要：**
> 结直肠癌（CRC）通常与表观遗传修饰相关，包括DNA甲基化的改变。最近的研究表明，肿瘤内的定植细菌可能影响CRC的发展，但细菌对表观遗传调控的作用尚不清楚。本研究探讨了来自常见于具有高CpG岛甲基化表型（CIMP）的CRC肿瘤中的两种细菌——齿垫梭杆菌（Fusobacterium periodonticum）和脆弱拟杆菌（Bacteroides fragilis）的脂多糖（LPS）对HT29结直肠癌细胞DNA甲基化的影响。将HT29细胞分别用齿垫梭杆菌LPS、脆弱拟杆菌LPS或两者联合处理。DNA甲基化通过简化代表性亚硫酸氢盐测序（RRBS）进行评估，并通过生物信息学分析鉴定差异甲基化的CpG位点。利用RT-qPCR分析了在CpG启动子甲基化发生改变的部分基因的表达情况。结果显示，齿垫梭杆菌LPS处理可在HT29细胞中同时诱导高甲基化与低甲基化，其中在特定启动子区域（包括PEPD和VAV3）附近观察到显著高甲基化，并伴随这些基因表达的降低。相比之下，脆弱拟杆菌LPS处理主要诱导低甲基化。当两种LPS联合处理时，产生了不同的甲基化模式，其中脆弱拟杆菌LPS可减弱齿垫梭杆菌LPS诱导的高甲基化。研究表明，细菌LPS可在HT29结直肠癌细胞中诱导DNA甲基化谱的动态变化，从而导致基因表达的改变。这一发现提示了肿瘤内定植细菌与结直肠癌DNA甲基化之间的全新联系，并首次揭示了细菌可能影响结直肠癌发生发展的潜在机制。

### 第二部分 AI 大师评价

本研究旨在探索肠道肿瘤相关细菌的脂多糖对结直肠癌细胞DNA甲基化的调控作用。作者采用RRBS和RT-qPCR技术，从甲基化图谱及基因表达两个层面揭示了不同细菌来源LPS的差异效应。研究发现齿垫梭杆菌LPS可导致特定基因启动子区域的高甲基化及表达下调，而脆弱拟杆菌LPS主要引起低甲基化，并能抑制前者的影响。这项工作首次建立了细菌代谢产物与肿瘤表观遗传改变之间的潜在因果联系，为理解细菌参与结直肠癌发生的机制提供了新视角，但其体外实验结果仍需在体内模型中进一步验证。

---

速递结束，祝您工作愉快！